Back Refine search Reset
Please choose a search criteria from below
Filters Clear all

45 results found in London

Sort by:
Showing 11 - 20 of 45 results

Professor John Bridgewater is a Consultant Medical Oncologist and Clinical Researcher at the UCL Cancer Institute. He specialises in gastrointestinal oncology, with a particular interest in biliary tract cancers and carcinomas of unknown primary origin.

After studying medicine at Oxford and University College London, he went on to specialise in Medical Oncology at the Middlesex, Mount Vernon and Royal Marsden Hospital. He was awarded a PhD by the Institute of Cancer Research for research into gene therapy. In 1999 he was appointed as a Senior Lecturer in Medical Oncology at UCL.

Professor Bridgewater leads the National Cancer Research Institute subgroup in hepatobiliary malignancy and also has a laboratory programme at the UCL Cancer Institute investigating carcinoma of unknown primary origin. He is also active in trials across the gastrointestinal portfolio and has been the chief investigator on a number of landmark studies into gastrointestinal and biliary tract cancers. As well as his clinical and research work, he also serves on a number of committees including The National Institute for Health and Care Excellence (NICE) and National Cancer Research Institute (NCRI). 

Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Bilary Cancer 
  • Bowel Cancer 
  • Cancer Unknown Primary
  • Gastro-intestinal Cancers
  • Liver Cancer 


Read more
25 years of experience

Dr Neil Rabin is a Consultant Haematologist who works at University College Hospital. His special interests include clinical trials evaluating new treatments for myeloma at diagnosis and at relapse.

Diseases, Medical Tests and Treatments
  • Clinical trials evaluating new treatments for myeloma at diagnosis and at relapse
Read more
Dr Naomi Fersht

Dr Naomi Fersht

0.00 miles

Dr Naomi Fersht

0.00 miles
28 years of experience

Dr Naomi Fersht is a consultant clinical oncologist at University College Hospital and the National Hospital for Neurology and Neurosurgery. She specialises exclusively in the management of primary and secondary brain and spinal tumours. This involves the use of both conventional and innovative radiotherapy techniques and chemotherapy.

Her special interests are brain oligometastases; meningiomas; pituitary tumours; the management of teenagers and young adults with brain tumours; and advanced radiotherapy techniques including radiosurgery.

She qualified from the University of Cambridge and her specialist training was at the Royal Marsden and University College Hospitals. Naomi's doctoral thesis, supervised by Nobel Laureate Sir Paul Nurse, was in cell cycle checkpoints.

Diseases, Medical Tests and Treatments
  • Brain oligometastases
  • Meningiomas
  • Pituitary tumours
  • The management of teenagers and young adults with brain tumours (age 16-24)
  • Advanced radiotherapy techniques including radiosurgery
Read more
Offers video consultation
20 years of experience
Haematological Malignancy

Dr Rismani is a Consultant Haematologist and clinical Lead for haematology based in London. He graduated from Imperial College Medical School in 2001, completing his specialist haematology training at Addenbrooke’s Hospital, Cambridge and University College London Hospitals.

Dr Rismani is a Honorary Clinical Lecturer at University College London (UCL).

Dr Rismani specialises in the diagnosis and management of blood cancers as well as general haematology, with special interest in the treatment of myeloma, lymphoma and chronic lymphocytic leukaemia (CLL).

In addition to his clinical work, Dr. Rismani also has particular expertise and a research interest in Waldenstrom’s Macroglobulinaemia, also known as Lymphoplasmacytic Lymphoma. He has been part of a number of international trials investigating this rare type of non-Hodgkin B cell lymphoma and has had his work published in a number of peer reviewed journals.

Read more
33 years of experience
Pancreaticobiliary Medicine (Bile Ducts & Pancreas), Hepatology

Professor Steve Pereira studied science and medicine at University of New South Wales, Sydney, with postgraduate training in gastroenterology and hepatology at Guy’s and King’s College hospitals, London. Pereira did advanced endoscopy training in Paris, Amsterdam and Indianapolis.

Since 2000, Steve Pereira has been a consultant at University College Hospital and at Royal Free Hospital since 2008. He is also a Professor of Hepatology and Gastroenterology at UCL.

Pereira's clinical and research interests focus on the causes, early diagnosis and treatment of liver and pancreatic cancer, as well as benign biliary and pancreatic diseases. These represent a vast number of patients referred for specialist opinion to UCLH, and the activity of the research group is linked closely with the clinical hepatopancreaticobiliary service at UCLH and the Royal Free.

Steve Pereira is past Chairman of the British Society of Gastroenterology Pancreatic Section and President of the Pancreatic Society of GB&I, and current Endoscopy lead on the HPB Board of London Cancer as well as serving on the research committees of the British Society of Gastroenterology and Guts UK.

In his spare time he likes to focus on fitness and he loves spending time with his family.

Diseases, Medical Tests and Treatments

  • Endoscopic-ultrasound guided gastrojejunostomy
  • Sphincter of Oddi dysfunction
  • Pancreatic cysts
  • BRAVO pH testingColonoscopy
  • Endoscopic Retrograde Cholangio Pancreatography (ERCP)
  • Flexible sigmoidoscopy
  • Gastroscopy
  • Pancreatic cysts
  • Hepato Pancreato-Bilary Cancers HPB
  • Endoscopy Unit
  • Pancreatobiliary service
  • Gastrointestinal services
Read more
21 years of experience
Bowel Cancer, Breast Cancer, Clinical Oncology + 10more

Dr Tom Richards is a consultant clinical oncologist specialising in the treatment of gastrointestinal (GI) and breast cancers. He is the clinical lead of the GI and breast cancer radiotherapy units at University College London NHS Hospital (UCLH) and honorary consultant in Clinical Oncology at The Whittington NHS Hospital. Prior to his appointment at UCLH, he was Clinical Oncology consultant in the GI and breast units at St Bartholomew's and The Royal London NHS Hospitals.

He is an experienced oncologist treating oesophagus, stomach, liver, pancreaticobiliary, colorectal and breast cancers. His specialist expertise is the delivery of radiotherapy, chemotherapy and biological targeted drugs for cancers at these sites. His particular interest is in technical radiotherapy treatments using cyberknife and intensity-modulated radiotherapy and motion management techniques using 4D-CT radiotherapy planning, deep inspiratory breath-hold and image-guided radiotherapy.

After graduation from Imperial College School of Medicine in London, his subsequent general internal medicine training was at King's College Hospital, London. He undertook specialist oncology training at St Bartholomew's and The Royal Marsden Hospitals in London. In 2015 he was awarded a PhD from the University of London for clinical and translation research performed at The Institute of Cancer Research, King's College London and The Royal Marsden Hospital. He studied the mechanisms by which therapeutic radiation affects normal tissues and strategies to detect and reduce late toxicity after curative treatment. He was awarded the Johnson and Johnson clinical research prize in 2012 for work contributing to his PhD.

He is a fellow of the Royal College of Radiologists and a member of The Royal College of Physicians, ESMO and ESTRO. He has spoken and chaired sessions at numerous national and international meetings. He is course tutor and examiner for the Institute of Cancer research MSc course and is the local principal investigator for several GI cancer clinical trials. Dr Richards is passionate to improve cancer outcomes, develop clinical research and deliver innovative multi-modality cancer treatments.

Diseases, Medical Tests and Treatments

  • Radiotherapy
  • Chemotherapy
  • SABR/Cyberknife
  • Intensity-modulated radiotherapy
  • SIRT (internal liver-directed radiotherapy)
  • Breast cancer
  • Colon cancer
  • Rectal cancer
  • Anal cancer
  • Oesophageal cancer
  • Liver cancer
  • Pancreatico-biliary cancer

Read more
Recommended by 1 specialist
22 years of experience

Dr Jonathan Lambert undertook his specialist training in haematology in London, based at University College Hospital, and completed a PhD in molecular haematology at the UCL Cancer Institute. He currently works as a consultant haemato-oncologist at UCH and Mount Vernon Cancer Centre and has particular expertise in managing lymphoma and myeloproliferative neoplasms (MPN).

Dr Lambert sits on a number of national committees, including the British Society for Haematology’s Haemato-oncology Task Force, as well as the MPN subgroup of the NCRI Haematological Oncology Clinical Studies Group. He is involved in running a wide variety of clinical studies at UCH and Mount Vernon Cancer Centre and is responsible for the clinical haematology undergraduate teaching programme at UCH.

Diseases, Medical Tests and Treatments
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Myeloproliferative neoplasms (MPN)
  • Autologous stem cell transplantation 
  • Blood diseases (clinical haematology)
Read more
Offers video consultation
28 years of experience

Dr Farrukh Shah is a consultant haematologist currently based at the Whittington hospital in London. Her area of specialism is general haematology and her areas of interest include thalaassaemia major, thalassaemia intermedia, iron overload disorders, haemachromatosis and iron deficiency. She leads the service at one of the largest centres for thalassaemia in the Uk and is recognised as an expert for these conditions internationally.

Dr Shah graduated from the University of Punjab in 1994 with an MBBS degree. She became a Member of the Royal College of Physicians in 1997 and a Member of the Royal College of Pathologists in 2001. She completed a Doctorate of Medicine in 2008 at University College London.

In addition, Dr Shah is also actively involved in clinical trials in thalassaemia and sickle cell disease. She has been a Chief Investigator and Primary investigator for a number of clinical trials in both disorders. She has also written book chapters and has published widely in peer-reviewed journals. Dr Shah is also the Chair of the UK Forum on Haemoglobin Disorders which is a multiprofessional organisation that advocates on behalf of patients with haemoglobinopathies. and the current Chair of the National haemoglobinopathy registry.

Diseases, Medical Tests and Treatments
  • Video Consultation
  • Sickle Cell Anaemia
  • Coagulation Disorders
  • Thalassaemia
  • Anaemia
Read more
25 years of experience
Advanced Melanoma, Medical Oncology, Renal Cancer + 1more

Dr Paul Nathan is an internationally renowned and well-respected Consultant Medical Oncologist with HCA Healthcare at LOC, The Harley Street Clinic, and The Wellington Hospital. His NHS practice is based at Mount Vernon Cancer Centre and UCLH. Dr Nathan’s clinical interests include melanoma of the skin, eye, and internal organs; kidney cancer (renal cell carcinoma), and rare skin cancers including Merkel cell carcinoma.

He originally trained in cancer immunology as a scientist, and following his Ph.D. and post-doctoral position in Pittsburgh, he ran a tumor immunology laboratory in the pharmaceutical industry. He then pursued clinical studies at Cambridge and UCL.

Dr Nathan has been a Consultant Medical Oncologist for nearly 20 years. He remains heavily involved in research and is the lead investigator for many clinical trials, particularly in the field of immunotherapy and targeted therapies. Most recently he has led the development of tebentafusp, the first drug proven to improve survival in advanced uveal melanoma. Dr Nathan has published over 100 papers, many of which are in the world’s leading medical journals, and has contributed to a number of medical textbooks. He is the Chair of the UK Uveal Melanoma Guidelines group and the UK Lead for Uveal Melanoma at the International Rare Cancer Initiative. He also leads the melanoma systemic therapies for the European cancer organisation’s (EORTC) melanoma group. Previously, Dr Nathan chaired the NCRI renal cancer clinical studies group. 


Diseases, Medical Tests and Treatments

  • Immunotherapy
  • Chemotherapy
  • Urological Cancer
  • Kidney Cancer
  • Renal Cancer
  • Skin Cancer
  • Melanoma
Read more
46 years of experience
General (Internal) Medicine, Paediatric (Pediatric) Cardiology

Dr John Walker is a Consultant Cardiologist at The Harley Street Clinic, HCA UK at University College Hospital and for the Barts Health NHS Trust. He specialises in cardiac rehabilitation, cardiovascular disease associated with inherited haemoglobinopathies - Thalassaemia and Sickle Cell disease.

He graduated from the University of Birmingham (honours in pre-clinical sciences) before specialising in cardiology at St.Thomas' Hospital & the Brompton Hospital, London and at the John Radcliffe Hospital, Oxford. His MD in 1983 involved studying the mechanical performance of human heart muscle.  In 1987 he was appointed as Consultant Cardiologist to University College and the Middlesex Hospitals.

As a consequence of his interest in patients with inherited diseases of haemoglobin, he established The Thalassaemia and Sickle Cardiac Centre at the Hatter Cardiovascular Institute, UCLH. This was the world's first cardiology clinic dedicated to diagnosing and treating young patients with inherited haemoglobinopathies.

Dr Walker is highly active in clinical research, with more than 60 publications in scientific and medical journals. He has made numberous book contribitions, including authorship of the cardiovascular disease chapeters of a major English language textbook of medicine. He was the Treasurer and then President of the British Association of Cardiovascular Rehabilitation from 2001 to 2006, as well as a Council member of the British Cardiovascular Society.


Diseases, Medical Tests and Treatments
  • Cardia Magnetic Resonance Scan (cardaic MRI) 
  • ECG (electrocardiogram) 
  • Paediatric congenital heart disease (CHD)
Read more